A study of infliximab administration method for tacrolimus-resistant active ulcerative colitis
Phase 2
- Conditions
- ulcerative colitis
- Registration Number
- JPRN-UMIN000013716
- Lead Sponsor
- Yokohama City University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Patients applied to the medically contraindicated of infliximab Patients during pregnancy Patients are taking concomitant any other biological therapies or cyclosporine Patients are determined to be inappropriate for administration of infliximab by doctors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rate of mucosal healing
- Secondary Outcome Measures
Name Time Method remission rate improvement rate steroid-sparing effect safety